PATENT CLAIM ANALYSIS

Application Number: 15898944
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "182000"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. In particular, the present invention relates to farnesoid X receptor (FXR) agonists for use in a method for the treatment of hepatitis B virus infection in a subject in need thereof.

Claim (Index 5):
The method of  claim 1 , wherein the farnesoid X receptor (FXR) agonist is selected from the group consisting of the compounds identified by the CAS REGISTRY NUMBERS 1192171-69-9 and 6ECDCA.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.51429
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14917958', '14775459', '10535042', '16342169', '15268119']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7896560644086904
- 35 USC 102 Novelty (BERT): 0.7818049905145961
- Combined Prediction Score: 0.788870957019281
- Mean Citation Score: 395.384054
- Max Citation Score: 944.469
- Similarity Product: 937.6585750354528

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test